Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of Ingavirin Forte Capsules at different doses for influenza and other acute respirator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection

Drugs mentioned

• Ingavirin Forte Capsules

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Influenza, Acute Respiratory Viral Infection | Phase 2 | Status: RECRUITING